Recent Clinical Data Links Tirzepatide to Higher Hair Loss Risks Than Semaglutide

By Korin Miller · Allure · 2026-08-05

Allure reports that new observational research shows a distinct gap in alopecia risks between major GLP-1 medications. While both tirzepatide and semaglutide are associated with thinning, patients using tirzepatide experienced hair loss at a rate of 4.2% compared to 2.88% for tho

Allure reports that new observational research shows a distinct gap in alopecia risks between major GLP-1 medications. While both tirzepatide and semaglutide are associated with thinning, patients using tirzepatide experienced hair loss at a rate of 4.2% compared to 2.88% for tho